IOL CHEMICALS & PHARM. | BROOKS LAB | IOL CHEMICALS & PHARM./ BROOKS LAB |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 13.4 | 524.3 | 2.5% | View Chart |
P/BV | x | 1.5 | 3.6 | 42.6% | View Chart |
Dividend Yield | % | 1.0 | 0.0 | - |
IOL CHEMICALS & PHARM. BROOKS LAB |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
IOL CHEMICALS & PHARM. Mar-23 |
BROOKS LAB Mar-23 |
IOL CHEMICALS & PHARM./ BROOKS LAB |
5-Yr Chart Click to enlarge
|
||
High | Rs | 537 | 142 | 378.5% | |
Low | Rs | 272 | 58 | 470.5% | |
Sales per share (Unadj.) | Rs | 377.6 | 25.6 | 1,475.8% | |
Earnings per share (Unadj.) | Rs | 23.7 | -12.6 | -188.5% | |
Cash flow per share (Unadj.) | Rs | 31.6 | -9.7 | -324.5% | |
Dividends per share (Unadj.) | Rs | 4.00 | 0 | - | |
Avg Dividend yield | % | 1.0 | 0 | - | |
Book value per share (Unadj.) | Rs | 256.8 | 29.9 | 857.7% | |
Shares outstanding (eoy) | m | 58.71 | 24.70 | 237.7% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.1 | 3.9 | 27.4% | |
Avg P/E ratio | x | 17.1 | -7.9 | -214.9% | |
P/CF ratio (eoy) | x | 12.8 | -10.3 | -124.9% | |
Price / Book Value ratio | x | 1.6 | 3.3 | 47.2% | |
Dividend payout | % | 16.9 | 0 | - | |
Avg Mkt Cap | Rs m | 23,743 | 2,466 | 962.8% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 1,682 | 160 | 1,051.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 22,171 | 632 | 3,507.8% | |
Other income | Rs m | 256 | 2 | 12,615.8% | |
Total revenues | Rs m | 22,427 | 634 | 3,537.0% | |
Gross profit | Rs m | 2,257 | -294 | -768.3% | |
Depreciation | Rs m | 462 | 70 | 656.9% | |
Interest | Rs m | 165 | 22 | 754.5% | |
Profit before tax | Rs m | 1,887 | -384 | -491.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 495 | -73 | -676.0% | |
Profit after tax | Rs m | 1,391 | -311 | -448.1% | |
Gross profit margin | % | 10.2 | -46.5 | -21.9% | |
Effective tax rate | % | 26.2 | 19.1 | 137.5% | |
Net profit margin | % | 6.3 | -49.1 | -12.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 9,667 | 276 | 3,501.6% | |
Current liabilities | Rs m | 5,025 | 330 | 1,521.8% | |
Net working cap to sales | % | 20.9 | -8.6 | -244.3% | |
Current ratio | x | 1.9 | 0.8 | 230.1% | |
Inventory Days | Days | 43 | 387 | 11.2% | |
Debtors Days | Days | 8 | 737 | 1.1% | |
Net fixed assets | Rs m | 11,017 | 820 | 1,343.7% | |
Share capital | Rs m | 587 | 247 | 237.7% | |
"Free" reserves | Rs m | 14,490 | 493 | 2,942.1% | |
Net worth | Rs m | 15,077 | 740 | 2,038.8% | |
Long term debt | Rs m | 0 | 0 | - | |
Total assets | Rs m | 20,684 | 1,096 | 1,887.3% | |
Interest coverage | x | 12.5 | -16.6 | -75.1% | |
Debt to equity ratio | x | 0 | 0 | - | |
Sales to assets ratio | x | 1.1 | 0.6 | 185.9% | |
Return on assets | % | 7.5 | -26.3 | -28.6% | |
Return on equity | % | 9.2 | -42.0 | -22.0% | |
Return on capital | % | 13.6 | -48.9 | -27.8% | |
Exports to sales | % | 26.7 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | 5,930 | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 5,930 | 0 | - | |
Fx outflow | Rs m | 6,052 | 0 | - | |
Net fx | Rs m | -122 | 0 | - |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,223 | -145 | -843.8% | |
From Investments | Rs m | -1,200 | 5 | -24,242.4% | |
From Financial Activity | Rs m | -41 | 114 | -36.0% | |
Net Cashflow | Rs m | -18 | -26 | 71.3% |
Indian Promoters | % | 48.2 | 63.6 | 75.8% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 1.7 | 3.9 | 44.0% | |
FIIs | % | 1.4 | 0.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 51.8 | 36.4 | 142.3% | |
Shareholders | 130,003 | 11,432 | 1,137.2% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare IOL CHEMICALS & PHARM. With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | IOL CHEMICALS & PHARM. | BROOKS LAB | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.17% | -2.00% | -0.92% |
1-Month | 8.06% | -3.19% | 1.39% |
1-Year | -1.36% | 50.00% | 51.34% |
3-Year CAGR | -11.55% | 11.82% | 14.50% |
5-Year CAGR | 15.45% | 17.03% | 19.09% |
* Compound Annual Growth Rate
Here are more details on the IOL CHEMICALS & PHARM. share price and the BROOKS LAB share price.
Moving on to shareholding structures...
The promoters of IOL CHEMICALS & PHARM. hold a 48.2% stake in the company. In case of BROOKS LAB the stake stands at 63.6%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of IOL CHEMICALS & PHARM. and the shareholding pattern of BROOKS LAB.
Finally, a word on dividends...
In the most recent financial year, IOL CHEMICALS & PHARM. paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.9%.
BROOKS LAB paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of IOL CHEMICALS & PHARM., and the dividend history of BROOKS LAB.
For a sector overview, read our pharmaceuticals sector report.
Asian share markets are mixed today after US shares extended their losing streak to the longest since January 2024.